Published on 18 Dec 2023 on Simply Wall St. via Yahoo Finance
CONMED Corporation's (NYSE:CNMD) P/S Is On The Mark
It's not a stretch to say that CONMED Corporation's (NYSE:CNMD) price-to-sales (or "P/S") ratio of 3x right now seems quite "middle-of-the-road" for companies in the Medical Equipment industry in the United States, where the median P/S ratio is around 3.1x. Although, it's not wise to simply ignore the P/S without explanation as investors may be disregarding a distinct opportunity or a costly mistake.
Check out our latest analysis for CONMED
